is tirzepatide or semaglutide more effective for weight loss vs. Semaglutide: What You Should Know Tirzepatide vs. Semaglutide Which Is

Choosing Between Semaglutide and Tirzepatide for Microdosing From a pharmacology standpoint, semaglutide is a pure GLP-1 receptor agonist , while tirzepatide is a dual GIP/GLP-1 agonist that activates both GIP and GLP-1 receptors.[2,4] That dual mechanism likely contributes to tirzepatides strong weight-loss results at full doses compared with semaglutide in head-to-head and indirect comparisons.[2,7] In the context of microdosing: Some clinicians and patients feel that microdosing tirzepatide provides robust appetite control even at relatively low doses, though this is based largely on real-world experience rather than large trials

In December 2025, the FDA approved the Wegovy pill, the first oral GLP-1 receptor agonist cleared specifically for weight management in adults, and clinical trial data show it produces weight loss comparable to the weekly injection

Side effects for both injectable drugs are generally mild

This transition requires attention